News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|July 29, 2020

Pharmaceutical Executive Global Digest®

Click here to download the August 2020 edition.

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement
Global

Related Content

Advertisement
Stock.adobe.com deal

Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu

ByNicholas Jacobus
May 13th 2026
Stock.adobe.com collaboration deal

GSK Enters Exclusive Collaboration with SBP Group to Accelerate Bepirovirsen at Launch in Mainland China

ByNicholas Jacobus
May 11th 2026
Stock.adobe.com acquisition deal

Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals

ByNicholas Jacobus
May 7th 2026
Charlie Lyon

What Elements is the Conversation About Bringing Pharma Manufacturing Home Missing?

ByMike Hollan,Charlie Lyon
May 7th 2026
Stock.adobe.com

Asembia ASX26: Adjusting Strategies and Building Relationships: Q&A with Jessica Lovett

ByMike Hollan,Jessica Lovett
May 1st 2026
Advertisement
Advertisement

Trending on PharmExec

1

Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal

2

Marty Makary Out as FDA Commissioner: Report

3

The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff

4

From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box

5

President Trump Planning to Fire FDA Commissioner Marty Makary: Report

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us